These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 679446)

  • 1. Effects of indomethacin on the vascular abnormalities of Bartter's syndrome.
    Richards CJ; Mark AL; Van Orden DE; Kaloyanides GJ
    Circulation; 1978 Sep; 58(3 Pt 1):544-9. PubMed ID: 679446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of indomethacin in a patient with Bartter's syndrome: evidence against a primary role of prostaglandin in this disorder.
    Etzioni A; Chaimovitz C; Levi Y; Benderli A; Better OS
    Pediatr Res; 1980 Dec; 14(12):1395-7. PubMed ID: 7010289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of altered vascular responsiveness in Bartter's syndrome by indomethacin treatment.
    Shimoyama R
    J Clin Endocrinol Metab; 1980 Oct; 51(4):908-11. PubMed ID: 6999001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Sar1-ala8-angiotensin II on blood pressure and renin in Bartter's syndrome, before and after treatment with prostaglandin synthetase inhibitors.
    Rudin A; Aurell M; Hansson L; Westberg G
    Scand J Clin Lab Invest; 1979 Oct; 39(6):543-50. PubMed ID: 119300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of prostaglandins in the pathogenesis of Bartter's syndrome.
    Fichman MP; Telfer N; Zia P; Speckart P; Golub M; Rude R
    Am J Med; 1976 May; 60(6):785-97. PubMed ID: 798488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the kallikrein-kinin system and vascular reactivity in Bartter's syndrome.
    Rodriguez-Portales JA; Lopez-Moreno JM; Mahana D
    Hypertension; 1985; 7(6 Pt 1):1017-22. PubMed ID: 2416684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Bartter's syndrome with indomethacin.
    Garin EH; Fennell RS; Iravani A; Richard GA
    Am J Dis Child; 1980 Mar; 134(3):258-61. PubMed ID: 6767392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses to antiotensin II antagonist before and after treatment with indomethacin in Bartter's syndrome.
    Sasaki H; Okumura M; Asano T; Arakawa K; Kawasaki T
    Br Med J; 1977 Oct; 2(6093):995-6. PubMed ID: 922403
    [No Abstract]   [Full Text] [Related]  

  • 9. Indomethacin in Bartter's syndrome: does the syndrome represent a state of hyperprostaglandinism?
    Donker AJ; de Jong PE; van Eps LW; Brentjens JR; Bakker K; Doorenbos H
    Nephron; 1977; 19(4):200-13. PubMed ID: 917167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's syndrome.
    Griffing GT; Aurecchia SA; Sindler BH; Melby JC
    J Clin Pharmacol; 1982; 22(11-12):505-12. PubMed ID: 6761369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of a girl with the neonatal form of Bartter's syndrome.
    Nakagawa Y; Toya K; Natsume H; Nasuda K; Takeuchi H; Kubota A; Ogawa H; Igarashi Y
    Endocr J; 1997 Apr; 44(2):275-81. PubMed ID: 9228463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Increased renal prostaglandin E2 secretion in Bartter's syndrome].
    Schwarz HA; Weidmann P; Messerli FH; Zia PK; Flammer J; Reubi RC
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1870-2. PubMed ID: 929154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin synthetase inhibitors in Bartter's syndrome. Effect on immunoreactive prostaglandin E excretion.
    Bowden RE; Gill JR; Radfar N; Taylor AA; Keiser HR
    JAMA; 1978 Jan; 239(2):117-21. PubMed ID: 412983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bartter's syndrome without hyperplasia of the juxtaglomerular apparatus, treated with indomethacin.
    Kornerup HJ; Pedersen EB; Petersen VP
    Acta Med Scand; 1978; 204(3):235-9. PubMed ID: 696424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bartter's syndrome--observations on the pathophysiology.
    Solomon LR; Bobinski H; Astley P; Goldby FS; Mallick NP
    Q J Med; 1982; 51(203):251-70. PubMed ID: 7146310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril and Bartter's syndrome.
    Sasaki H; Okumura M; Kawasaki T
    Nephron; 1985; 41(3):303-4. PubMed ID: 3903530
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis].
    Favre L; Glasson P; Flory ED; Dray F; Vallotton MB
    Schweiz Med Wochenschr; 1979 Feb; 109(5):142-7. PubMed ID: 441720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypokalemia and prostaglandin overproduction in Bartter's syndrome.
    Senba S; Konishi K; Saruta T; Ozawa Y; Kato E; Amagasaki Y; Nakata I
    Nephron; 1984; 37(4):257-63. PubMed ID: 6379486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of indomethacin upon the renin--angiotensin system in patients with Bartter's syndrome.
    Vierhapper H; Waldhäusl W
    Eur J Clin Invest; 1980 Apr; 10(2 Pt 1):119-24. PubMed ID: 6780358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis.
    Gill JR; Frölich JC; Bowden RE; Taylor AA; Keiser HR; Seyberth HW; Oates JA; Bartter FC
    Am J Med; 1976 Jul; 61(1):43-51. PubMed ID: 820194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.